AAAAAA
Results: 1-25/62
Authors:
Wuster, C
Abs, R
Bengtsson, BA
Bennmarker, H
Feldt-Rasmussen, U
Hernberg-Stahl, E
Monson, JP
Westberg, B
Wilton, P
Citation: C. Wuster et al., The infuence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineraldensity, J BONE MIN, 16(2), 2001, pp. 398-405
Authors:
Drake, WM
Parkinson, C
Akker, SA
Monson, JP
Besser, GM
Trainer, PJ
Citation: Wm. Drake et al., Successful treatment of resistant acromegaly with a growth hormone receptor antagonist, EUR J ENDOC, 145(4), 2001, pp. 451-456
Authors:
Monson, JP
Citation: Jp. Monson, Sensitivity to growth hormone, standardization of IGF-I measurements - 5thKIGS/KIMS Expert Meeting on Growth and Growth Disorders - Windsor, UK, February 2-3, 2001 - Preface, HORMONE RES, 55, 2001, pp. 1-2
Authors:
Monson, JP
Citation: Jp. Monson, Biochemical markers of individual response to growth hormone replacement in adults, HORMONE RES, 55, 2001, pp. 49-54
Authors:
Monson, JP
Rosenfeld, RG
Citation: Jp. Monson et Rg. Rosenfeld, Sensitivity to growth hormone - The perspective - Round table discussion, HORMONE RES, 55, 2001, pp. 65-67
Authors:
Johnston, LB
Chew, SL
Lowe, D
Reznek, R
Monson, JP
Savage, MO
Citation: Lb. Johnston et al., Investigating familial endocrine neoplasia syndromes in children, HORMONE RES, 55, 2001, pp. 31-35
Authors:
Monson, JP
Coyte, D
Kaltsas, G
Jenkins, PJ
Chew, SL
Grossman, AB
Besser, GM
Citation: Jp. Monson et al., Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply, CLIN ENDOCR, 55(5), 2001, pp. 696-697
Authors:
Siddiqi, A
Foley, RR
Britton, KE
Sibtain, A
Plowman, PN
Grossman, AB
Monson, JP
Besser, GM
Citation: A. Siddiqi et al., The role of I-123-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to I-131-scanning: avoidance of negative therapeutic uptake due to stunning, CLIN ENDOCR, 55(4), 2001, pp. 515-521
Authors:
Mukherjee, JJ
Kaltsas, GA
Islam, N
Plowman, PN
Foley, R
Hikmat, J
Britton, KE
Jenkins, PJ
Chew, SL
Monson, JP
Besser, GM
Grossman, AB
Citation: Jj. Mukherjee et al., Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with I-131-meta-iodobenzylguanidine (I-131-mIBG), CLIN ENDOCR, 55(1), 2001, pp. 47-60
Authors:
Miraki-Moud, F
Jenkins, PJ
Fairclough, PD
Jordan, S
Bustin, SA
Jones, AM
Lowe, DG
Monson, JP
Grossman, AB
Besser, GM
Camacho-Hubner, C
Citation: F. Miraki-moud et al., Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly, CLIN ENDOCR, 54(4), 2001, pp. 499-508
Authors:
Drake, WM
Rodriguez-Arnao, J
Weaver, JU
James, IT
Coyte, D
Spector, TD
Besser, GM
Monson, JP
Citation: Wm. Drake et al., The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitaryadults: a 5-year study, CLIN ENDOCR, 54(4), 2001, pp. 525-532
Authors:
Drake, WM
Howell, SJ
Monson, JP
Shalet, SM
Citation: Wm. Drake et al., Optimizing GH therapy in adults and children, ENDOCR REV, 22(4), 2001, pp. 425-450
Authors:
Monson, JP
Besser, GM
Citation: Jp. Monson et Gm. Besser, Premature mortality and hypopituitarism, LANCET, 357(9272), 2001, pp. 1972-1973
Authors:
Trainer, PJ
Drake, WM
Perry, LA
Taylor, NF
Besser, GM
Monson, JP
Citation: Pj. Trainer et al., Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly, J CLIN END, 86(7), 2001, pp. 2989-2992
Authors:
Aylwin, SJB
Welch, JP
Davey, CL
Geddes, JF
Wood, DF
Besser, GM
Grossman, AB
Monson, JP
Burrin, JM
Citation: Sjb. Aylwin et al., The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas, J CLIN END, 86(6), 2001, pp. 2476-2483
Authors:
Christiansen, JS
Bengtsson, BA
Thorner, MO
Hintz, R
Sonksen, PH
Cohen, P
Clemmons, D
Strasburger, CJ
Carlsson, L
Tanaka, T
Robinson, I
Jorgensen, JO
Johannson, G
Clayton, PE
Cowell, CT
Malozowski, SN
Hankinson, S
Yee, D
Baxter, R
Swerdlow, A
Rosenfeld, R
Fradkin, JE
Nishi, Y
Monson, JP
van den Berghe, G
Carroll, PV
Takala, J
van der Lely, AJ
Pollak, MN
LeRoith, D
Tachibana, K
Kappelgaard, AM
Langbakke, I
Lippe, B
Wilton, P
Stein, P
Salazar, DE
Maneatis, T
Blethen, SL
Cutler, GB
Blum, WF
Svanberg, E
Gertner, JM
Shimatsu, A
Takahashi, H
Citation: Js. Christiansen et al., Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society, J CLIN END, 86(5), 2001, pp. 1868-1870
Authors:
Kaltsas, GA
Isidori, AM
Florakis, D
Trainer, PJ
Camacho-Hubner, C
Afshar, F
Sabin, I
Jenkins, JP
Chew, SL
Monson, JP
Besser, GM
Grossman, AB
Citation: Ga. Kaltsas et al., Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity, J CLIN END, 86(4), 2001, pp. 1645-1652
Authors:
Kaltsas, G
Korbonits, M
Heintz, E
Mukherjee, JJ
Jenkins, PJ
Chew, SL
Reznek, R
Monson, JP
Besser, GM
Foley, R
Britton, KE
Grossman, AB
Citation: G. Kaltsas et al., Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors, J CLIN END, 86(2), 2001, pp. 895-902
Authors:
Frajese, G
Drake, WM
Loureiro, RA
Evanson, J
Coyte, D
Wood, DF
Grossman, AB
Besser, GM
Monson, JP
Citation: G. Frajese et al., Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy, J CLIN END, 86(11), 2001, pp. 5172-5175
Authors:
Hernberg-Stahl, E
Luger, A
Abs, R
Bengtsson, BA
Feldt-Rasmussen, U
Wilton, P
Westberg, B
Monson, JP
Citation: E. Hernberg-stahl et al., Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency, J CLIN END, 86(11), 2001, pp. 5277-5281
Authors:
Owen, NJ
Sohaib, SAA
Peppercorn, PD
Monson, JP
Grossman, AB
Besser, GM
Reznek, RH
Citation: Nj. Owen et al., MRI of pancreatic neuroendocrine tumours, BR J RADIOL, 74(886), 2001, pp. 968-973
Authors:
Monson, JP
Citation: Jp. Monson, The epidemiology of endocrine tumours, ENDOCR-R CA, 7(1), 2000, pp. 29-36
Authors:
Monson, JP
Citation: Jp. Monson, Growth hormone (GH) replacement therapy: cancer in adults treated with GH, GROWTH H I, 10, 2000, pp. S50-S51
Authors:
Monson, JP
Citation: Jp. Monson, Optimal strategy for management of pituitary disease in the growth hormone-deficient teenager, J PED END M, 13, 2000, pp. 1343-1348
Authors:
Jenkins, PJ
Akker, S
Chew, SL
Besser, GM
Monson, JP
Grossman, AB
Citation: Pj. Jenkins et al., Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration, CLIN ENDOCR, 53(6), 2000, pp. 719-724